Delivery Order SPE2DB20D3103-SPE2DB24FP4N7
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $10,010.18 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of ABRAXANE 100 mg vials to the U.S. government. The $8,395.98 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of May 29, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,375.16 contract is for the delivery of ABRAXANE 100 MG VIALS and has an ultimate completion date of March 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The fixed-price contract, valued at $2,960.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract has a completion date of February 1, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCVUA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4,567,874,660 units of the pharmaceutical product ABRAXANE 100 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,382.51 and a period of performance ending on April 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is...
This is a federal contract award to Amerisourcebergen Drug Corp for the delivery of ABRAXANE 100 mg vials, a specialty pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order with a firm fixed price of $42,197.40 and a period of performance through September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medication to support federal healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for ABRAXANE 100 MG VIALS, with a ceiling value of $3,374.68 and a firm fixed price pricing type. The contract has a period of performance through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7ZM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $9,439.35 and is a firm fixed-price Delivery Order with an ultimate completion date of June 6, 2024. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...